Employing bioactive compounds derived from Ipomoea obscura (L.) to evaluate potential inhibitor for SARS‐CoV‐2 main protease and ACE2 protein

by Saravana Prabha Poochi, Murugesh Easwaran, Balamuralikrishnan Balasubramanian, Mohan Anbuselvam, Arun Meyyazhagan, Sungkwon Park, Haripriya Kuchi Bhotla, Jeeva Anbuselvam, Vijaya Anand Arumugam, Sasikala Keshavarao, Gopalakrishnan Velliyur Kanniyappan, Manikantan Pappusamy, Tanushri Kaul
Published 2020-06-01